A carregar...
The Impact of Systemic Therapy Following Ductal Carcinoma In Situ
Following local therapy for ductal carcinoma in situ (DCIS), tamoxifen reduces the risk of ipsilateral and contralateral breast cancer by 30%–50%. Studies of tamoxifen in women with resected DCIS have not shown any effect on overall or cancer-specific survival. The adverse event profile of tamoxifen...
Na minha lista:
| Publicado no: | J Natl Cancer Inst Monogr |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4999067/ https://ncbi.nlm.nih.gov/pubmed/20956830 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jncimonographs/lgq021 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|